United Kingdom · Biotechnology startup

Pepgen

PepGen is empowering nucleic acid therapeutics to go the distance.

Funding reportedLast round: Post ipo equity

BiotechnologyOxford, United Kingdom

What company datasets say Pepgen raised

Funding, as reported

Reported in all239.7Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateFeb 2024
Investors listed20

Founders and team

From Pepgen's own website: 6 on the team.

  • Rod LozanoVice President, Information Technology
  • Melissa MichaelsExecutive Director, Head of Regulatory Affairs CMC
  • Habib Joseph DableNon-Executive Director
  • Heidi HensonNon-Executive Director
  • Lisa WymanNon-Executive Director
  • Sarah VaccaExecutive Director, Clinical Operations

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Pepgen in front of investors. Or tell us what we have wrong.

List your startupSend a correction